Evidence for the use of mineralocorticoid receptor antagonists in the treatment of coronary artery disease and post-angioplasty restenosis

Article ID	Journal	Published Year	Pages	File Type
8540367	Vascular Pharmacology	2018	27 Pages	PDF

Keywords

11β-Hydroxysteroid dehydrogenase type 2 STEMI ICAM MRA 11β-hsd2 SMCs LSD IGF ECs ROS Atherosclerosis aldosterone Mineralocorticoid receptor antagonist Apoe apolipoprotein E ST-elevation myocardial infarction coronary artery disease Neointima formation restenosis Diabetes mellitus Low sodium diet Smooth muscle cells Endothelial cells CAD Insulin growth factor intercellular adhesion molecule Nitric oxide Reactive oxygen species Mineralocorticoid receptor glucocorticoid receptor

Related Topics

Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine

Evidence for the use of mineralocorticoid receptor antagonists in the treatment of coronary artery disease and post-angioplasty restenosis

Authors

Jochen Dutzmann, Johann Bauersachs, Daniel G. Sedding,